Effects and mechanism of downregulation of survivin expression by RNA interference on proliferation and apoptosis of lung cancer cells

P SeveC DumontetChemoresistance in non-small cell lung cancerCurr Med Chem Anticancer Agents57388200510.2174/156801105335260415720263

MW LeeDS KimNY MinHT KimAkt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatinInt J Cancer12223802384200810.1002/ijc.2337118224693

AQ DongMJ KongZY MaJF QianXH XuDown-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude miceCell Biol Int31500507200710.1016/j.cellbi.2006.11.01717196841

E AshiharaRNA interference for cancer therapiesGan To Kagaku Ryoho3720332041201021084799

N NakashimaCL HuangD LiuM UenoH YokomiseIntratumoral Wnt1 expression affects survivin gene expression in non-small cell lung cancerInt J Oncol37687694201020664938

I PorebskaE SobanskaM KosackaR JankowskaApoptotic regulators: P53 and survivin expression in non-small cell lung cancerCancer Genomics Proteomics7331335201021156966

W ZhengX MaD WeiT WangY MaS YangMolecular cloning and bioinformatics analysis of a novel spliced variant of survivin from human breast cancer cellsDNA Seq16321328200516329164

ME HornPM WaterhouseRapid match-searching for gene silencing assessmentBioinformatics2619321937201010.1093/bioinformatics/btq31820601440

N IchiteM ChouguleAR PatelT JacksonS SafeM SinghInhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancerMol Cancer Ther930033014201010.1158/1535-7163.MCT-09-110420978159

A BiranM BrownsteinR HaklaiY KloogDownregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapyInt J Cancer128691701201110.1002/ijc.2536720473860

DC AltieriValidating survivin as a cancer therapeutic targetNat Rev Cancer34654200310.1038/nrc96812509766

F CappuzzoFR HirschE RossiEpidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small cell lung cancerJ Natl Cancer Inst97643655200510.1093/jnci/dji11215870435

F LiG AmbrosiniEY ChuControl of apoptosis and mitotic spindle checkpoint by survivinNature396580584199810.1038/251419859993

S SinghalA VachaniD Antin-OzerkisLR KaiserSM AlbeldaPrognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a reviewClin Cancer Res1139743986200510.1158/1078-0432.CCR-04-266115930332

A SuzukiT ItoH KawanoSurvivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell deathOncogene1913461353200010.1038/sj.onc.120342910713676

SK ChiouMK JonesAS TarnawskiSurvivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyondMed Sci Monit9PI2529200312709681

K YonesakaK TamuraT KurataSmall interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycinInt J Cancer118812820200610.1002/ijc.2135016108013

JI ChaoHF LiuThe blockage of survivin and securin expression increases the cytochalasin B-induced cell death and growth inhibition in human cancer cellsMol Pharmacol69154164200616219911

A SuzukiM HayashidaT ItoSurvivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activationOncogene1932253234200010.1038/sj.onc.120366510918579

AM VerhagenDL VauxCell death regulation by the mammalian IAP antagonist Diablo/SmacApoptosis7163166200210.1023/A:101431861595511865200

DP BanksJ PlesciaDC AltieriSurvivin does not inhibit caspase-3 activityBlood9640024003200011186274

Y ShiSurvivin structure: crystal unclearNat Struct Biol7620623200010.1038/7790410932241

DS O’ConnorD GrossmanJ PlesciaRegulation of apoptosis at cell division by p34cdc2 phosphorylation of survivinProc Natl Acad Sci USA971310313107200011069302

JS JangKM KimKH KangPolymorphisms in the survivin gene and the risk of lung cancerLung Cancer603139200810.1016/j.lungcan.2007.09.00817961802

NH NabilsiRR BroaddusDS LooseDNA methylation inhibits p53-mediated survivin repressionOncogene2820462050200910.1038/onc.2009.6219363521